The preliminary decision to block Cosette's acquisition of Mayne Pharma sets a bad precedent and would weaken Australia's capital markets.

BlackDoctor.org, a health platform that reaches 20 million people, launched a new initiative, Generational Health, that aims ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

Once a niche asset class serving grocers and food processors, cold storage has evolved into one of the most dynamic, data-driven, and capital-intensive property types in commercial real estate.

Over the past few decades, the Triangle’s life sciences sector has been a monolithic growth engine, but now it’s bifurcated.

Alnylam Pharmaceuticals, Inc. is rated Hold due to high expectations, competitive threats, and revenue expansion. Learn more ...

The US Health Resources and Services Administration (HRSA) revealed the initial nine drugs to be included in the 340B rebate ...

But Doustdar also seems to recognize what he has in Novo Nordisk, the 100-year-old pharma that brought insulin to the masses, ...

Chip Frazier, a retired United States Air Force officer, is running a campaign to secure one of two seats open on Oak ...

Shares in Mayne Pharma plunged by nearly a third on Friday after it emerged that Australia's treasurer was considering blocking a A$672 million ($435 million) offer for the company from now-reluctant ...

In its fourth year, the daylong conference touched on a number of pain points in the health media space and offered best practices for navigating these challenges.